Study aim: 1- Determining and comparing the levels of pain, disability, and changes in neck range of motion after applying kinesiotape (KT) with a facilitative and inhibitory method compared to a placebo group in individuals with Forward Head Posture (FHP)." 4- Determining and comparing CVA, CHA, and EAD after applying KT with facilitative and inhibitory methods compared to the placebo group in individuals with FHP. 5- Determining and comparing the electromyographic activity of neck muscles in static conditions and during functional activity after applying KT. Design: This clinical trial is designed with a placebo control group, parallel groups, is single-blind, and randomized. To randomize the participants, sealed envelopes and a block randomization method were used. Settings and conduct: After the initial assessment in the laboratory, patients will undergo 4 sessions of treatment with kinesiotape. The colleague responsible for recording the data is blinded. Participants/Inclusion and exclusion criteria: Inclusion criteria: - Males and females aged 20 to 40 years - CVA size in the range of 43-48 (Moderate FHP) - Presence of trigger points in the upper trapezius muscle - VAS score in the range of 4 to 7 Exclusion criteria: - Fracture or trauma and Musculoskeletal surgery on the neck and shoulder area - Severe deformities - sensitivity and Allergy to KT taping - Recent neck treatment - Individuals using any muscle relaxants or sedatives. Intervention groups: One of the groups receives facilitative kinesiotaping on the upper trapezius muscle, the other group receives inhibitory kinesiotaping on the upper trapezius muscle. The placebo group receives tape without tension on the neck. Main outcome variables: Improving the Condition of Patients with Neck Pain: A Clinical Guideline for Colleagues on the Use of Kinesiotape.